The ADMIRE Network, funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) aims to strengthen international collaboration on ‘Strategies for therapeutic targeting of the Aldosterone-Mineralocorticoid Receptor signaling pathway’.
The ADMIRE network consists of a core group of 20 researchers from 6 European countries, covering a broad spectrum of research areas from molecular biology, epigenetics, immunology, translational and clinical medicine, to pharmacology and chemical biology. Together, they evaluate potential new indications and explore innovative approaches for therapeutic targeting of the Aldosterone-Mineralocorticoid Receptor signaling pathway. The present initiative builds on the previous EU COST action ADMIRE and serves as an open forum for all researchers interested in aldosterone, the mineralocorticoid receptor, or related topics.